微芯生物：11月19日召开董事会会议

Company Overview - Microchip Biotech (SH 688321) announced its third board meeting on November 19, 2025, which will be held in a hybrid format [1] - The meeting will review proposals including the revision and establishment of certain governance systems [1] Financial Performance - For the year 2024, Microchip Biotech's revenue composition is as follows: 97.96% from pharmaceutical manufacturing and 2.04% from other businesses [1] - As of the report date, the market capitalization of Microchip Biotech is 11.4 billion yuan [1]